Abstract
The objective was to confirm the long-term utility of magnesium salts treatment on a group of young patients suffering from episodic tension-type headache (ETTH). The study was carried out at the Outpatient Headache Center at the National Neurological Institute “C. Besta,” Milan, Italy, with 45 children/adolescents with ETTH reporting consecutively for treatment. Magnesium pidolate (2.25 g) was given twice per day for three months. Medication was not administered during the year of follow-up. No other treatment was provided at any time. Patients showed significant symptom reduction. Headache days decreased by 69.9%, whereas analgesics consumption was reduced by 65.4%. Overall disability levels improved by the greatest percent − 75.7%. MIDAS subscores improved as well (question A=58.0%; question B=22.5%). Although uncontrolled, these findings are encouraging and suggest that further, better controlled research investigations are warranted.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Annequin D, Tourniaire B, Massiou H (2000) Migraine and headache in children and adolescence. Pediatr Clinic North Am 37:617–631
Laurell K, Larsson B, Eeg-Olofsson O (2004) Prevalence of headaches in Swedish schoolchildren with a focus on tension type headache. Cephalalgia 24:380–388
Facchinetti F, Sances G, Borella P et al (1991) Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 31:298–301
Peikert A, Wilimzig C, Kohne-Volland R (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multicenter, placebo-controlled and double-blind randomized study. Cephalalgia 16:257–263
Pfaffenrath V, Wessely P, Meyer C et al (1996) Magnesium in the prophylaxis of migraine-a double-blind placebo-controlled study. Cephalalgia 16:436–440
Castelli S, Meossi C, Domenici R et al (1993) Magnesium prophylaxis of primary migraine and periodic migraine equivalents in children. Med Surg Pediatr 15:481–488
Wang F, Van Den Eeden SK, Ackerson LM et al (2003) Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 43:601–610
Barlow DH, Hersen M (1984) Single case experimental designs: strategies for studying behavior change, 2nd edn. Pergamon Press, New York
Grazzi L, Andrasik F, Usai S, Bussone G (2005) Magnesium as a treatment for paediatric tension-type headache: a clinical replication series. Neurol Sci 25:338–341
Altura BM, Altura BT (2001) Tension headaches and muscle tension: is there a role for magnesium? Med Hypotheses 57:705–713
Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders (2nd edn). Cephalalgia 24[Suppl 1]:1–160
Andrasik F (2001) Assessment of patients with headache. In: Turk DC, Melzack R (eds) Handbook of pain assessment, 2nd Edn. Guilford, New York, pp 454–474
D’Amico D, Mosconi P, Genco S et al (2001) The migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of Italian version. Cephalalgia 21:947–952
D’Amico D, Grazzi L, Usai S et al (2003) Use of disability Assessment Questionnaire in children and adolescents with headache: an Italian pilot study. Headache 43:767–773
Aloisi P, Marrelli A, Porto C et al (1997) Visual evoked potentials and serum magnesium levels in juvenile migraine patients. Headache 37:383–385
Castelli S, Meossi C, Domenici R et al (1993) Magnesium in the prophylaxis of primary headache and other periodic disorders in children. Pediatr Med Chir 15:481–488
Hermann C, Kim M, Blanchard EB (1995) Behavioral and prophylactic pharmacological intervention studies of pediatric migraine: an exploratory meta-analysis. Pain 60:239–256
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grazzi, L., Andrasik, F., Usai, S. et al. Magnesium as a preventive treatment for paediatric episodic tension-type headache: results at 1-year follow-up. Neurol Sci 28, 148–150 (2007). https://doi.org/10.1007/s10072-007-0808-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-007-0808-y